Anthropic IPO at Risk, Meta’s Muse Pop, Token Prices Fall, Open Source Gains Share, Alignment Fails

They argue “labs” is rhetorical cover that implies nonprofit research rather than shareholder-driven corporations, and that it conveniently muddies accountability when products cause harm. The panel repeatedly returns to U.S. product liability as the correct governance mechanism versus global committees.

Friedberg lists a rapid succession of releases across open-weight and closed models, emphasizing steep cost drops and the ability to run capable models locally. The panel’s core claim: the genie's out—policy that assumes centralized control is already outdated.

They cite data suggesting open-model token usage flipped dramatically (from mostly closed to mostly open) in roughly 12 weeks, which would pressure closed providers’ pricing and market share. This reframes “moats” away from model quality alone toward distribution, workflow integration, and premium niche performance.

Sacks argues Anthropic’s public statements about existential risk, plus calls to “pace the frontier” while shipping frontier models, create credibility and disclosure problems that spook public investors. Super-voting shares become especially controversial when leadership messaging appears inconsistent with shareholder value maximization.

Chamath frames token spend as poorly linked to customer revenue, making “token maxing” vulnerable to CFO pressure as models commoditize. Enterprises may migrate to cheaper hosted models or self-host open weights, reserving expensive frontier models for narrow, high-value use cases.